Related Experiment Videos
Correcting common errors in identifying cancer-specific serum peptide signatures.
Josep Villanueva1, John Philip, Carlos A Chaparro
1Protein Center, Molecular Biology Program, Engineering Resource Laboratory, Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Journal of Proteome Research
|August 9, 2005
Summary
This study developed a standardized peptidomics platform for biomarker discovery. The platform successfully identified 98 discriminant peptides in serum to distinguish thyroid cancer patients from healthy individuals.
Area of Science:
- Biochemistry and Molecular Biology
- Biomarker Discovery
- Analytical Chemistry
Background:
- Molecular signatures, patterns of biomolecules, are crucial for biomarker discovery.
- Noninvasive, single-readout measurements are ideal for clinical applications.
- Existing peptidomics platforms require optimization for standardization and bias reduction.
Purpose of the Study:
- To develop and standardize a peptidomics platform for reliable biomarker discovery.
- To optimize clinical and analytical variables affecting measurement accuracy.
- To introduce a novel algorithm for spectral alignment and data analysis.
Main Methods:
- Developed a magnetics-based, automated solid-phase extraction coupled with MALDI-TOF mass spectrometry.
- Evaluated and standardized variables including blood collection, serum handling, and spectral processing.
- Introduced the "Entropycal" minimal entropy algorithm for spectral alignment and data mining.
Main Results:
- Standardized a peptidomics platform reducing bias from clinical and analytical variables.
- The "Entropycal" algorithm improved spectral alignment and retained distinguishing spectral information.
- Identified 98 discriminant peptides capable of distinguishing thyroid cancer patients from healthy controls.
Conclusions:
- The optimized and standardized peptidomics platform enables reliable biomarker discovery.
- The "Entropycal" algorithm enhances data analysis for biomarker identification.
- This approach addresses patient-related biases, paving the way for clinical translation.